Processa Pharmaceuticals Appoints Gregory J. Flesher Operations Chief
Benzinga Newsdesk 11 hours ago
ManagementNews
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company advancing differentiated therapeutic programs for immunological and inflammatory
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company advancing differentiated therapeutic programs for immunological and inflammatory diseases, today announced key leadership appointments to support the Company’s next phase of growth:
- Gregory J. Flesher, Chief Operating Officer